NUTRACEUTICALS CONTAINING CURCUMIN

Brand Owner Address Description
CURCUCOMPLETE Eniva Health 2700 Campus Drive Plymouth MN 55441 Nutraceuticals containing curcumin for the treatment of Inflammation, Heart Disease, Bronchitis and Asthma, Depression, Fatigue, Diabetes, Alzheimer; Dietary supplements containing curcumin; Dietary supplements containing curcumin, Boswellia Extract, Nettle Extract, Urtica dioica leaf, Pineapple Bromelain, Ginger Root, Black Pepper Fruit Extract; Dietary supplements consisting primarily of curcumin, Boswellia Extract, Nettle Extract, Urtica dioica leaf, Pineapple Bromelain, Ginger Root, Black Pepper Fruit Extract; Dietary supplements for human consumption containing curcumin; Dietary and nutritional supplements containing curcumin; Dietary and nutritional supplements containing curcumin, Boswellia Extract, Nettle Extract, Urtica dioica leaf, Pineapple Bromelain, Ginger Root, Black Pepper Fruit Extract; Dietary food supplements containing curcumin; Food supplements containing curcumin; Herbal supplements containing curcumin; Homeopathic supplements containing curcumin; Mineral supplements containing curcumin; Mineral food supplements containing curcumin; Mineral nutritional supplements containing curcumin; Natural herbal supplements containing curcumin; Nutraceuticals for use as a dietary supplement containing curcumin; Nutritional supplements containing curcumin; Nutritional supplements containing curcumin for Joint health, immune health, cardiovascular health, neurologic health, reducing inflammation, skin health and body health; Nutritional supplements in the form of capsule containing curcumin;CURCUMA COMPLETE;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. All multiple myeloma cell lines examined showed constitutively active I?B kinase (IKK), I?B? phosphorylation and constitutively active NF-?B. Curcumin, a chemopreventive agent, suppressed constitutive I?B? phosphorylation through inhibition of IKK activity and downregulated NF-?B. Curcumin also downregulated expression of NF-?B-regulated gene products such as I?B?, Bcl-2, Bcl-xL, cyclin D1 and interleukin-6. Consequently, curcumin suppressed multiple myeloma cell proliferation and arrested cells at the G1/S phase of the cell cycle. Curcumin also induced apoptosis and chemosensitivity to vincristine. Overall, results presented herein provide a molecular basis for the treatment of multiple myeloma patients with this pharmacologically safe agent.